China Merchants China Direct Investments Limited
0133.HK
Hong Kong Stock Exchange21.68
HKD
+1.06
- -
China Merchants China Direct Investments Limited
0133.HK
(Hong Kong Stock Exchange)
Recent
price
21.68
P/E
ratio
- -
div
yld
- -
ROIC.AI
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- Similar Companies
- Business
- China Merchants China Direct Investments Limited (0133.HK) is a Hong Kong-listed investment holding company backed by China Merchants Group that specializes in direct investments across high-growth sectors in China, including financial services, culture, media and consumption, information technology, manufacturing, and real estate; it targets high-tech projects with investments typically not exceeding $10 million through initial public offerings, pre-listing placements, and up to 10% of net asset value in listed shares such as China concept shares, H shares, and B shares. Founded in 2006 and headquartered at Three Pacific Place in Hong Kong, the company operates primarily in the People's Republic of China, focusing on portfolio companies in autonomous driving, AI large models, robotics, biotechnology, action cameras, and payment services. Its key investees include Pony.ai, Flexiv, Insta360 (Arashi Vision), iFlytek, YZY Biopharma, Immvira, Kimi, and China UnionPay affiliates. The company generates revenue principally from net gains on financial assets at fair value through profit or loss and investment income, with the information technology segment as its prime contributor; it maintains a strong balance sheet featuring zero debt, high profitability margins exceeding 70%, and return on equity around 28%. Recent developments include portfolio company milestones such as Insta360's listing on the SSE STAR Market in 2025 with a debut surge of 285% to over 70 billion yuan market cap; Flexiv's completion of Series C billion-dollar financing and recognition as a China Unicorn Enterprise; Pony.ai's Nasdaq listing, strategic partnership with Uber, and multiple autonomous driving testing approvals; Xunfei Healthcare's HKEX main board listing as the first medical large model stock; along with director changes effective June 2025 and interim results announcement for the six months ended June 2024.